Stock Price
1.09
Daily Change
-0.02 -1.80%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.19

Avita Medical reported AUD-9.92M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Celltrion KRW 331.35B 270.18B Sep/2025
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Cochlear AUD 91.9M 113.2M Jun/2025
CSL USD 497.5M 1.51B Jun/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 6.89B 1.44B Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Mayne Pharma AUD -103.68M 68.4M Jun/2024
Medical Developments International AUD -105K 409K Jun/2025
Nanosonics AUD 5.46M 4.3M Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
Pharma Mar EUR -4.1M 27.47M Sep/2025
Polynovo AUD 1.28M 1.41M Jun/2024
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Qiagen NV USD 130.04M 33.79M Sep/2025
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
ResMed USD 392.59M 44.05M Dec/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024
Tilray USD -44.93M 44.61M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025